📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. (2021)

First Author: Samaras JJ

Attributed to: Developing the E. coli GlycoCell funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12934-021-01588-1

PubMed Identifier: 34030723

Publication URI: http://europepmc.org/abstract/MED/34030723

Type: Journal Article/Review

Volume: 20

Parent Publication: Microbial cell factories

Issue: 1

ISSN: 1475-2859